Global Medical Inhaled Nitric Oxide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Medical Inhaled Nitric Oxide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 76

Published Date: 01 Nov 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

According to our (Global Info Research) latest study, the global Medical Inhaled Nitric Oxide market size was valued at USD 1077.4 million in 2021 and is forecast to a readjusted size of USD 1921.1 million by 2028 with a CAGR of 8.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Medical Inhaled Nitric Oxide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by NO Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.

Key Features:
Global Medical Inhaled Nitric Oxide market size and forecasts, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market size and forecasts, by NO Concentration and by Application, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market shares of main players, shipments in revenue ($ Million), sales quantity (M L), and ASP (US$/L), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Inhaled Nitric Oxide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Inhaled Nitric Oxide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, Linde and Air Liquide. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Medical Inhaled Nitric Oxide market is split by NO Concentration and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by NO Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by NO Concentration
800 ppm
100 ppm
Others

Market segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases

Major players covered
Mallinckrodt
Linde
Air Liquide

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Inhaled Nitric Oxide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Inhaled Nitric Oxide, with price, sales, revenue and global market share of Medical Inhaled Nitric Oxide from 2017 to 2022.
Chapter 3, the Medical Inhaled Nitric Oxide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Inhaled Nitric Oxide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by NO Concentration and application, with sales market share and growth rate by no concentration, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Inhaled Nitric Oxide market forecast, by regions, no concentration and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Inhaled Nitric Oxide.
Chapter 14 and 15, to describe Medical Inhaled Nitric Oxide sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Medical Inhaled Nitric Oxide Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by NO Concentration
1.3.1 Overview: Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration: 2017 Versus 2021 Versus 2028
1.3.2 800 ppm
1.3.3 100 ppm
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Inhaled Nitric Oxide Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Near-term and Pre-term Infants PPHN
1.4.3 Children and Adult ARDS
1.4.4 Other Diseases
1.5 Global Medical Inhaled Nitric Oxide Market Size & Forecast
1.5.1 Global Medical Inhaled Nitric Oxide Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Medical Inhaled Nitric Oxide Sales Quantity (2017-2028)
1.5.3 Global Medical Inhaled Nitric Oxide Average Price (2017-2028)

2 Manufacturers Profiles
2.1 Mallinckrodt
2.1.1 Mallinckrodt Details
2.1.2 Mallinckrodt Major Business
2.1.3 Mallinckrodt Medical Inhaled Nitric Oxide Product and Services
2.1.4 Mallinckrodt Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Mallinckrodt Recent Developments/Updates
2.2 Linde
2.2.1 Linde Details
2.2.2 Linde Major Business
2.2.3 Linde Medical Inhaled Nitric Oxide Product and Services
2.2.4 Linde Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Linde Recent Developments/Updates
2.3 Air Liquide
2.3.1 Air Liquide Details
2.3.2 Air Liquide Major Business
2.3.3 Air Liquide Medical Inhaled Nitric Oxide Product and Services
2.3.4 Air Liquide Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Air Liquide Recent Developments/Updates

3 Competitive Environment: Medical Inhaled Nitric Oxide by Manufacturer
3.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Manufacturer (2017-2022)
3.2 Global Medical Inhaled Nitric Oxide Revenue by Manufacturer (2017-2022)
3.3 Global Medical Inhaled Nitric Oxide Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Medical Inhaled Nitric Oxide by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Medical Inhaled Nitric Oxide Manufacturer Market Share in 2021
3.4.2 Top 6 Medical Inhaled Nitric Oxide Manufacturer Market Share in 2021
3.5 Medical Inhaled Nitric Oxide Market: Overall Company Footprint Analysis
3.5.1 Medical Inhaled Nitric Oxide Market: Region Footprint
3.5.2 Medical Inhaled Nitric Oxide Market: Company Product Type Footprint
3.5.3 Medical Inhaled Nitric Oxide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Medical Inhaled Nitric Oxide Market Size by Region
4.1.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2028)
4.1.2 Global Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2028)
4.1.3 Global Medical Inhaled Nitric Oxide Average Price by Region (2017-2028)
4.2 North America Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.3 Europe Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.4 Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.5 South America Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.6 Middle East and Africa Medical Inhaled Nitric Oxide Consumption Value (2017-2028)

5 Market Segment by NO Concentration
5.1 Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
5.2 Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2017-2028)
5.3 Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2028)

6 Market Segment by Application
6.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
6.2 Global Medical Inhaled Nitric Oxide Consumption Value by Application (2017-2028)
6.3 Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2028)

7 North America
7.1 North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
7.2 North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
7.3 North America Medical Inhaled Nitric Oxide Market Size by Country
7.3.1 North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
7.3.2 North America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe
8.1 Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
8.2 Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
8.3 Europe Medical Inhaled Nitric Oxide Market Size by Country
8.3.1 Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
8.3.2 Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific
9.1 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
9.2 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Medical Inhaled Nitric Oxide Market Size by Region
9.3.1 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America
10.1 South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
10.2 South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
10.3 South America Medical Inhaled Nitric Oxide Market Size by Country
10.3.1 South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
10.3.2 South America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa
11.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
11.2 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Medical Inhaled Nitric Oxide Market Size by Country
11.3.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Market Dynamics
12.1 Medical Inhaled Nitric Oxide Market Drivers
12.2 Medical Inhaled Nitric Oxide Market Restraints
12.3 Medical Inhaled Nitric Oxide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Medical Inhaled Nitric Oxide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Inhaled Nitric Oxide
13.3 Medical Inhaled Nitric Oxide Production Process
13.4 Medical Inhaled Nitric Oxide Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Inhaled Nitric Oxide Typical Distributors
14.3 Medical Inhaled Nitric Oxide Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration, (USD Million), 2017 & 2021 & 2028
Table 2. Global Medical Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 4. Mallinckrodt Major Business
Table 5. Mallinckrodt Medical Inhaled Nitric Oxide Product and Services
Table 6. Mallinckrodt Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Mallinckrodt Recent Developments/Updates
Table 8. Linde Basic Information, Manufacturing Base and Competitors
Table 9. Linde Major Business
Table 10. Linde Medical Inhaled Nitric Oxide Product and Services
Table 11. Linde Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Linde Recent Developments/Updates
Table 13. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 14. Air Liquide Major Business
Table 15. Air Liquide Medical Inhaled Nitric Oxide Product and Services
Table 16. Air Liquide Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Air Liquide Recent Developments/Updates
Table 18. Global Medical Inhaled Nitric Oxide Sales Quantity by Manufacturer (2017-2022) & (M L)
Table 19. Global Medical Inhaled Nitric Oxide Revenue by Manufacturer (2017-2022) & (USD Million)
Table 20. Global Medical Inhaled Nitric Oxide Average Price by Manufacturer (2017-2022) & (US$/L)
Table 21. Market Position of Manufacturers in Medical Inhaled Nitric Oxide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 22. Head Office and Medical Inhaled Nitric Oxide Production Site of Key Manufacturer
Table 23. Medical Inhaled Nitric Oxide Market: Company Product Type Footprint
Table 24. Medical Inhaled Nitric Oxide Market: Company Product Application Footprint
Table 25. Medical Inhaled Nitric Oxide New Market Entrants and Barriers to Market Entry
Table 26. Medical Inhaled Nitric Oxide Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 28. Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 29. Global Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 30. Global Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 31. Global Medical Inhaled Nitric Oxide Average Price by Region (2017-2022) & (US$/L)
Table 32. Global Medical Inhaled Nitric Oxide Average Price by Region (2023-2028) & (US$/L)
Table 33. Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 34. Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 35. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2017-2022) & (USD Million)
Table 36. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2023-2028) & (USD Million)
Table 37. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2022) & (US$/L)
Table 38. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2023-2028) & (US$/L)
Table 39. Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 40. Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 41. Global Medical Inhaled Nitric Oxide Consumption Value by Application (2017-2022) & (USD Million)
Table 42. Global Medical Inhaled Nitric Oxide Consumption Value by Application (2023-2028) & (USD Million)
Table 43. Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2022) & (US$/L)
Table 44. Global Medical Inhaled Nitric Oxide Average Price by Application (2023-2028) & (US$/L)
Table 45. North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 46. North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 47. North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 48. North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 49. North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 50. North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 51. North America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 52. North America Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 53. Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 54. Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 55. Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 56. Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 57. Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 58. Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 59. Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 60. Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 62. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 63. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 64. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 65. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 66. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 67. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 68. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 69. South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 70. South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 71. South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 72. South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 73. South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 74. South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 75. South America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 76. South America Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 78. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 79. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 80. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 81. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 82. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 83. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 84. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 85. Medical Inhaled Nitric Oxide Raw Material
Table 86. Key Manufacturers of Medical Inhaled Nitric Oxide Raw Materials
Table 87. Medical Inhaled Nitric Oxide Typical Distributors
Table 88. Medical Inhaled Nitric Oxide Typical Customers
List of Figures
Figure 1. Medical Inhaled Nitric Oxide Picture
Figure 2. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by NO Concentration in 2021
Figure 4. 800 ppm Examples
Figure 5. 100 ppm Examples
Figure 6. Others Examples
Figure 7. Global Medical Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Application in 2021
Figure 9. Near-term and Pre-term Infants PPHN Examples
Figure 10. Children and Adult ARDS Examples
Figure 11. Other Diseases Examples
Figure 12. Global Medical Inhaled Nitric Oxide Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 13. Global Medical Inhaled Nitric Oxide Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 14. Global Medical Inhaled Nitric Oxide Sales Quantity (2017-2028) & (M L)
Figure 15. Global Medical Inhaled Nitric Oxide Average Price (2017-2028) & (US$/L)
Figure 16. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Manufacturer in 2021
Figure 17. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Manufacturer in 2021
Figure 18. Producer Shipments of Medical Inhaled Nitric Oxide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Medical Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Top 6 Medical Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2021
Figure 21. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 22. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 23. North America Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 24. Europe Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 25. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 26. South America Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 27. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 28. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 29. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by NO Concentration (2017-2028)
Figure 30. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2028) & (US$/L)
Figure 31. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 32. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Application (2017-2028)
Figure 33. Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2028) & (US$/L)
Figure 34. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 35. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 36. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 37. North America Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 38. United States Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 42. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 43. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 44. Europe Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 45. Germany Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 51. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 52. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 54. China Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. Korea Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 61. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 62. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 63. South America Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 64. Brazil Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 67. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 68. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 69. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 70. Turkey Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Egypt Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Africa Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Medical Inhaled Nitric Oxide Market Drivers
Figure 75. Medical Inhaled Nitric Oxide Market Restraints
Figure 76. Medical Inhaled Nitric Oxide Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide in 2021
Figure 79. Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
Figure 80. Medical Inhaled Nitric Oxide Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Mallinckrodt
Linde
Air Liquide
btl

Related Reports

Global Medical Inhaled Nitric Oxide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22

Global Medical Inhaled Nitric Oxide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Devices & Consumables

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Medical Inhaled Nitric Oxide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Medical Inhaled Nitric Oxide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 76

Published Date: 01 Nov 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

According to our (Global Info Research) latest study, the global Medical Inhaled Nitric Oxide market size was valued at USD 1077.4 million in 2021 and is forecast to a readjusted size of USD 1921.1 million by 2028 with a CAGR of 8.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Medical Inhaled Nitric Oxide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by NO Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.

Key Features:
Global Medical Inhaled Nitric Oxide market size and forecasts, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market size and forecasts, by NO Concentration and by Application, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2017-2028
Global Medical Inhaled Nitric Oxide market shares of main players, shipments in revenue ($ Million), sales quantity (M L), and ASP (US$/L), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Inhaled Nitric Oxide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Inhaled Nitric Oxide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, Linde and Air Liquide. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Medical Inhaled Nitric Oxide market is split by NO Concentration and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by NO Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by NO Concentration
800 ppm
100 ppm
Others

Market segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases

Major players covered
Mallinckrodt
Linde
Air Liquide

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Inhaled Nitric Oxide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Inhaled Nitric Oxide, with price, sales, revenue and global market share of Medical Inhaled Nitric Oxide from 2017 to 2022.
Chapter 3, the Medical Inhaled Nitric Oxide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Inhaled Nitric Oxide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by NO Concentration and application, with sales market share and growth rate by no concentration, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Inhaled Nitric Oxide market forecast, by regions, no concentration and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Inhaled Nitric Oxide.
Chapter 14 and 15, to describe Medical Inhaled Nitric Oxide sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Medical Inhaled Nitric Oxide Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by NO Concentration
1.3.1 Overview: Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration: 2017 Versus 2021 Versus 2028
1.3.2 800 ppm
1.3.3 100 ppm
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Inhaled Nitric Oxide Consumption Value by Application: 2017 Versus 2021 Versus 2028
1.4.2 Near-term and Pre-term Infants PPHN
1.4.3 Children and Adult ARDS
1.4.4 Other Diseases
1.5 Global Medical Inhaled Nitric Oxide Market Size & Forecast
1.5.1 Global Medical Inhaled Nitric Oxide Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Medical Inhaled Nitric Oxide Sales Quantity (2017-2028)
1.5.3 Global Medical Inhaled Nitric Oxide Average Price (2017-2028)

2 Manufacturers Profiles
2.1 Mallinckrodt
2.1.1 Mallinckrodt Details
2.1.2 Mallinckrodt Major Business
2.1.3 Mallinckrodt Medical Inhaled Nitric Oxide Product and Services
2.1.4 Mallinckrodt Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Mallinckrodt Recent Developments/Updates
2.2 Linde
2.2.1 Linde Details
2.2.2 Linde Major Business
2.2.3 Linde Medical Inhaled Nitric Oxide Product and Services
2.2.4 Linde Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Linde Recent Developments/Updates
2.3 Air Liquide
2.3.1 Air Liquide Details
2.3.2 Air Liquide Major Business
2.3.3 Air Liquide Medical Inhaled Nitric Oxide Product and Services
2.3.4 Air Liquide Medical Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Air Liquide Recent Developments/Updates

3 Competitive Environment: Medical Inhaled Nitric Oxide by Manufacturer
3.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Manufacturer (2017-2022)
3.2 Global Medical Inhaled Nitric Oxide Revenue by Manufacturer (2017-2022)
3.3 Global Medical Inhaled Nitric Oxide Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Medical Inhaled Nitric Oxide by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Medical Inhaled Nitric Oxide Manufacturer Market Share in 2021
3.4.2 Top 6 Medical Inhaled Nitric Oxide Manufacturer Market Share in 2021
3.5 Medical Inhaled Nitric Oxide Market: Overall Company Footprint Analysis
3.5.1 Medical Inhaled Nitric Oxide Market: Region Footprint
3.5.2 Medical Inhaled Nitric Oxide Market: Company Product Type Footprint
3.5.3 Medical Inhaled Nitric Oxide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Medical Inhaled Nitric Oxide Market Size by Region
4.1.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2028)
4.1.2 Global Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2028)
4.1.3 Global Medical Inhaled Nitric Oxide Average Price by Region (2017-2028)
4.2 North America Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.3 Europe Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.4 Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.5 South America Medical Inhaled Nitric Oxide Consumption Value (2017-2028)
4.6 Middle East and Africa Medical Inhaled Nitric Oxide Consumption Value (2017-2028)

5 Market Segment by NO Concentration
5.1 Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
5.2 Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2017-2028)
5.3 Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2028)

6 Market Segment by Application
6.1 Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
6.2 Global Medical Inhaled Nitric Oxide Consumption Value by Application (2017-2028)
6.3 Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2028)

7 North America
7.1 North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
7.2 North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
7.3 North America Medical Inhaled Nitric Oxide Market Size by Country
7.3.1 North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
7.3.2 North America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe
8.1 Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
8.2 Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
8.3 Europe Medical Inhaled Nitric Oxide Market Size by Country
8.3.1 Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
8.3.2 Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific
9.1 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
9.2 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
9.3 Asia-Pacific Medical Inhaled Nitric Oxide Market Size by Region
9.3.1 Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America
10.1 South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
10.2 South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
10.3 South America Medical Inhaled Nitric Oxide Market Size by Country
10.3.1 South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
10.3.2 South America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa
11.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2028)
11.2 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2028)
11.3 Middle East & Africa Medical Inhaled Nitric Oxide Market Size by Country
11.3.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Market Dynamics
12.1 Medical Inhaled Nitric Oxide Market Drivers
12.2 Medical Inhaled Nitric Oxide Market Restraints
12.3 Medical Inhaled Nitric Oxide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Medical Inhaled Nitric Oxide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Inhaled Nitric Oxide
13.3 Medical Inhaled Nitric Oxide Production Process
13.4 Medical Inhaled Nitric Oxide Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Inhaled Nitric Oxide Typical Distributors
14.3 Medical Inhaled Nitric Oxide Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration, (USD Million), 2017 & 2021 & 2028
Table 2. Global Medical Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 4. Mallinckrodt Major Business
Table 5. Mallinckrodt Medical Inhaled Nitric Oxide Product and Services
Table 6. Mallinckrodt Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. Mallinckrodt Recent Developments/Updates
Table 8. Linde Basic Information, Manufacturing Base and Competitors
Table 9. Linde Major Business
Table 10. Linde Medical Inhaled Nitric Oxide Product and Services
Table 11. Linde Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Linde Recent Developments/Updates
Table 13. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 14. Air Liquide Major Business
Table 15. Air Liquide Medical Inhaled Nitric Oxide Product and Services
Table 16. Air Liquide Medical Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Air Liquide Recent Developments/Updates
Table 18. Global Medical Inhaled Nitric Oxide Sales Quantity by Manufacturer (2017-2022) & (M L)
Table 19. Global Medical Inhaled Nitric Oxide Revenue by Manufacturer (2017-2022) & (USD Million)
Table 20. Global Medical Inhaled Nitric Oxide Average Price by Manufacturer (2017-2022) & (US$/L)
Table 21. Market Position of Manufacturers in Medical Inhaled Nitric Oxide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 22. Head Office and Medical Inhaled Nitric Oxide Production Site of Key Manufacturer
Table 23. Medical Inhaled Nitric Oxide Market: Company Product Type Footprint
Table 24. Medical Inhaled Nitric Oxide Market: Company Product Application Footprint
Table 25. Medical Inhaled Nitric Oxide New Market Entrants and Barriers to Market Entry
Table 26. Medical Inhaled Nitric Oxide Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 28. Global Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 29. Global Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 30. Global Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 31. Global Medical Inhaled Nitric Oxide Average Price by Region (2017-2022) & (US$/L)
Table 32. Global Medical Inhaled Nitric Oxide Average Price by Region (2023-2028) & (US$/L)
Table 33. Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 34. Global Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 35. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2017-2022) & (USD Million)
Table 36. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration (2023-2028) & (USD Million)
Table 37. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2022) & (US$/L)
Table 38. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2023-2028) & (US$/L)
Table 39. Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 40. Global Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 41. Global Medical Inhaled Nitric Oxide Consumption Value by Application (2017-2022) & (USD Million)
Table 42. Global Medical Inhaled Nitric Oxide Consumption Value by Application (2023-2028) & (USD Million)
Table 43. Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2022) & (US$/L)
Table 44. Global Medical Inhaled Nitric Oxide Average Price by Application (2023-2028) & (US$/L)
Table 45. North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 46. North America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 47. North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 48. North America Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 49. North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 50. North America Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 51. North America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 52. North America Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 53. Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 54. Europe Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 55. Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 56. Europe Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 57. Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 58. Europe Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 59. Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 60. Europe Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 62. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 63. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 64. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 65. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 66. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 67. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 68. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 69. South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 70. South America Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 71. South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 72. South America Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 73. South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2017-2022) & (M L)
Table 74. South America Medical Inhaled Nitric Oxide Sales Quantity by Country (2023-2028) & (M L)
Table 75. South America Medical Inhaled Nitric Oxide Consumption Value by Country (2017-2022) & (USD Million)
Table 76. South America Medical Inhaled Nitric Oxide Consumption Value by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2017-2022) & (M L)
Table 78. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by NO Concentration (2023-2028) & (M L)
Table 79. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2017-2022) & (M L)
Table 80. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Application (2023-2028) & (M L)
Table 81. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Region (2017-2022) & (M L)
Table 82. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity by Region (2023-2028) & (M L)
Table 83. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Region (2017-2022) & (USD Million)
Table 84. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value by Region (2023-2028) & (USD Million)
Table 85. Medical Inhaled Nitric Oxide Raw Material
Table 86. Key Manufacturers of Medical Inhaled Nitric Oxide Raw Materials
Table 87. Medical Inhaled Nitric Oxide Typical Distributors
Table 88. Medical Inhaled Nitric Oxide Typical Customers
List of Figures
Figure 1. Medical Inhaled Nitric Oxide Picture
Figure 2. Global Medical Inhaled Nitric Oxide Consumption Value by NO Concentration, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by NO Concentration in 2021
Figure 4. 800 ppm Examples
Figure 5. 100 ppm Examples
Figure 6. Others Examples
Figure 7. Global Medical Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Application in 2021
Figure 9. Near-term and Pre-term Infants PPHN Examples
Figure 10. Children and Adult ARDS Examples
Figure 11. Other Diseases Examples
Figure 12. Global Medical Inhaled Nitric Oxide Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 13. Global Medical Inhaled Nitric Oxide Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 14. Global Medical Inhaled Nitric Oxide Sales Quantity (2017-2028) & (M L)
Figure 15. Global Medical Inhaled Nitric Oxide Average Price (2017-2028) & (US$/L)
Figure 16. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Manufacturer in 2021
Figure 17. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Manufacturer in 2021
Figure 18. Producer Shipments of Medical Inhaled Nitric Oxide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Medical Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Top 6 Medical Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2021
Figure 21. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 22. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 23. North America Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 24. Europe Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 25. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 26. South America Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 27. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value (2017-2028) & (USD Million)
Figure 28. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 29. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by NO Concentration (2017-2028)
Figure 30. Global Medical Inhaled Nitric Oxide Average Price by NO Concentration (2017-2028) & (US$/L)
Figure 31. Global Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 32. Global Medical Inhaled Nitric Oxide Consumption Value Market Share by Application (2017-2028)
Figure 33. Global Medical Inhaled Nitric Oxide Average Price by Application (2017-2028) & (US$/L)
Figure 34. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 35. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 36. North America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 37. North America Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 38. United States Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 42. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 43. Europe Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 44. Europe Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 45. Germany Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 51. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 52. Asia-Pacific Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 54. China Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. Korea Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 61. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 62. South America Medical Inhaled Nitric Oxide Sales Quantity Market Share by Country (2017-2028)
Figure 63. South America Medical Inhaled Nitric Oxide Consumption Value Market Share by Country (2017-2028)
Figure 64. Brazil Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by NO Concentration (2017-2028)
Figure 67. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by Application (2017-2028)
Figure 68. Middle East & Africa Medical Inhaled Nitric Oxide Sales Quantity Market Share by Region (2017-2028)
Figure 69. Middle East & Africa Medical Inhaled Nitric Oxide Consumption Value Market Share by Region (2017-2028)
Figure 70. Turkey Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Egypt Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Africa Medical Inhaled Nitric Oxide Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Medical Inhaled Nitric Oxide Market Drivers
Figure 75. Medical Inhaled Nitric Oxide Market Restraints
Figure 76. Medical Inhaled Nitric Oxide Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide in 2021
Figure 79. Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
Figure 80. Medical Inhaled Nitric Oxide Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Mallinckrodt
Linde
Air Liquide
btl

Related Reports

Global Medical Inhaled Nitric Oxide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Medical Inhaled Nitric Oxide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Medical Devices & Consumables

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

jiaGou

Add To Cart

gouMai

Buy Now